Director of Retina Research Wills Eye Hospital Professor of Ophthalmology, Jefferson Medical College
Ophthalmology
Dr. Allen S. Ho, MD
|
|
Give Review
Allen is an expert in the field of Ophthalmology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He has 9 awards "America's Top Doctors", "Philadelphia Magazine", "Fellow (FACS)", "Top Docs of Philadelphia", "Best Doctors of America", "Top Docs of Main Line", "Top Docs of New Jersey", "Super Doctor" and "Fellow (FAAO)". Dr. Allen S. Ho is a published physician. He published 87 publications, including: 'Macular hole.'
Publications
- Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
- En face optical coherence tomography and angiography of talc retinopathy.
- Cell therapy for retinal Disease.
- En Face Optical Coherence Tomography of Bilateral Myopic Macular Retinoschisis.
- In Vivo Assessment of Macular Vascular Density in Healthy Human Eyes Using Optical Coherence Tomography Angiography.
- COTTON-WOOL SPOTS AFTER USE OF MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION.
- Reopening of a Full-Thickness Macular Hole 2 Years After Pharmacologic Closure With Ocriplasmin.
- Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients with Wet Age-Related Macular Degeneration.
- Therapies for Macular Edema Associated with Central Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology.
- Efficacy of Intravitreal Ocriplasmin on Vitreomacular Traction and Full-Thickness Macular Holes.
- Perioperative retina evaluation of the cataract surgery patient.
- A prospective pilot study of intravitreal aflibercept for the treatment of Chronic central serous chorioretinopathy: the CONTAIN study.
- Baseline Choroidal Thickness as a Predictor for Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.
- Three Year Treatment Outcomes for Neovascular Age-Related Macular Degeneration using a "Treat and Extend" Regimen.
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration.
- Low Vision Depression Prevention Trial in Age-Related Macular Degeneration: A Randomized Clinical Trial.
- Paracentral Acute Middle Maculopathy in Nonischemic Central Retinal Vein Occlusion.
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six-Week Results of the VIEW Studies.
- Improving Function in Age-Related Macular Degeneration: A Randomized Clinical Trial.
- Peripapillary choroidal neovascularization in pars planitis.
- Interventions for Toxoplasma Retinochoroiditis: A Report by the American Academy of Ophthalmology.
- A novel method of draining intraoperative choroidal detachments during 23-gauge pars plana vitrectomy.
- Interim Results from the International Trial of Second Sight's Visual Prosthesis.
- Ranibizumab for Eyes Previously Treated With Pegaptanib or Bevacizumab Without Clinical Response.
- ASSOCIATION BETWEEN HIGH-RISK Disease LOCI AND RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION.
- Iatrogrenic retinal breaks.
- 23-Gauge Transconjunctival Pars Plana Vitrectomy for Removal of Retained Lens Fragments.
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study.
- Evolution of severe lightning maculopathy visualized with spectral domain optical coherence tomography.
- Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology.
- Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.
- Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26.
- The Microsurgical Safety Task Force: evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery.
- Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.
- Characteristics of endophthalmitis in patients with the Boston keratoprosthesis.
- Streptococcus mitis endophthalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injection.
- Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival.
- Short-term outcomes of 23-gauge pars plana vitrectomy.
- Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment.
- Intravitreal bevacizumab (avastin) in central retinal vein occlusion.
- Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.
- Postoperative complications associated with 25-gauge pars plana vitrectomy.
- Perioperative and operative considerations in diabetics.
- Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates.
- Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment.
- Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years.
- Photodynamic therapy in young patients.
- Diagnostic and therapeutic challenges. High grade fever and bronchitis.
- Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularization.
- Light energy, cataract surgery, and progression of age-related macular degeneration.
- Changing trends in the microbiologic aspects of postcataract endophthalmitis.
- Ultraviolet and near-blue light effects on the eye.
- Idiopathic juxtafoveal telangiectasis in association with celiac sprue.
- Retinal detachment from inadvertent intraocular injection of botulinum toxin A.
- Lipemia retinalis associated with branch retinal vein occlusion.
- Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review.
- Retinal vascular occlusive Disease in a child with neurofibromatosis.
- Intraoperative indocyanine green videoangiography in subretinal surgery.
- Color Doppler imaging identifies four syndromes of the retrobulbar circulation in patients with amaurosis fugax and central retinal artery occlusions.
- Intraretinal leakage of indocyanine green dye.
- Macular hole.
- Diabetes and retinopathy.
- Pasteurella multocida keratitis and corneal laceration from a cat scratch.
- Rapidly progressive optic disk neovascularization after diabetic papillopathy.
- Macular fibrosis associated with talc retinopathy.
- Laser treatment in eyes with drusen.
- Color Doppler hemodynamics of giant cell arteritis.
- Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography.
- Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
- Color Doppler imaging of the ocular ischemic syndrome.
- A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration.
- Photodynamic therapy update.
- Unusual immunogammopathy maculopathy.
- The natural history of idiopathic subfoveal choroidal neovascularization.
- A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration.
- Age-related macular degeneration.
- Psychophysical evidence for rod vulnerability in age-related macular degeneration.
- Hemodynamic alterations in the acute retinal necrosis syndrome.
- One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
- Patient-initiated second medical opinions: their necessity and economic cost.
- Foveolar choroidal blood flow in age-related macular degeneration.
- Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group.
- Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study.
- [Treatment of neovascular age-related macular degeneration with antiangiogenic drugs].
- Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.
- Risk factors for choroidal neovascularization and vision Loss in the fellow eye study of CNVPT.
Schools
UCLA School Of Medicine
Stanford University Medical Center
Memorial Sloan Kettering Cancer Center
Harvard University
National Institutes Of Health National Cancer Institute
Procedures Preformed
- Advanced Robotic Surgery
- Antrostomy and Antrotomy (Sinus Surgery)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ethmoidectomy (Sinus Surgery)
- View All
Conditions Treated
- Allergic Rhinitis
- Bell's Palsy
- Cancer of Floor of Mouth
- Carcinoma in Situ
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Ophthalmology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- Fellow (FACS)
- Top Docs of Philadelphia
- Best Doctors of America
- Top Docs of Main Line
- Top Docs of New Jersey
- Super Doctor
- Fellow (FAAO)
Education
-
Wills Eye Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Cooper University Health Care -
Thomas Jefferson University Hospital -
Abington Hospital - Jefferson Health
Drug Facts
| NPI NUMBER | 1386829604 | |
| NPPES Provider LastName | HO | |
| NPPES Provider FirstName | ALLEN | |
| NPPES Provider ZIPCode | 900485901 | |
| NPPES Provider State | CA | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 25.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386829604 |
| Last Name Of The Provider | HO |
| First Name Of The Provider | ALLEN |
| View All |
Similar Doctors
|
|
Dr. Gary S. Bellack, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Bozena B. Wrobel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Kedeshian, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John W. House, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irwin Harris, MD |
|
|
Dr. Konstantin C. Salkinder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin L. Hopp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mamdouh S. Bahna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Delaware F. Harris II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renu V. Jivrajka, MD
This Doctor is OpenDoctor Recommended.
|